Related by context. All words. (Click for frequent words.) 83 treat nephropathic cystinosis 80 aldehyde dehydrogenase ALDH2 deficiency 76 Ribavirin causes 76 non alcoholic steatohepatitis 76 kidney urologic 75 Vitrasert R 75 Crofelemer budesonide foam 75 Shows Promise Against 74 Disease IBD 74 CYT# potent vascular disrupting 74 candidates Azedra TM 74 renal failure interstitial lung 74 essential thrombocythemia ET 74 Treatment Shows Promise 73 Initiates Enrollment 73 Initiates Clinical Trial 73 humanized therapeutic 73 cause cardiac channelopathies 73 Chronic Lung 73 nephropathic cystinosis 73 myocardial infarction ventricular fibrillation 73 CYP#A# CYP#D# 73 Alzheimer disease Peripheral Artery 73 included exfoliative dermatitis 73 Maven Semantic 73 Completes Patient Enrollment 73 DG# compounds targeting 73 sores onychomycosis nail 73 ALTROPANE R 72 non porcine pancreatic 72 topically applied SEPA 72 treat musculoskeletal metabolic 72 Acute Exacerbations 72 TRIOLEX HE# APOPTONE HE# 72 TRANSDUR ® 72 Receives Orphan Drug Designation 72 vascular occlusive diseases 72 TNF Tumor Necrosis Factor 72 oncolytic virus therapies 72 Amgen Neulasta R 72 Complicated Skin 72 Meets Primary Endpoint 72 interferon alpha IFN 72 R Saizen R 72 brand ciclesonide HFA 72 HYVISC ® treatment 72 vaginal candidiasis 72 disorder Creutzfeldt Jakob 72 Mouse Model 72 platform HDL Mimetic 72 urinary bladder wall 72 pralatrexate injection folate analogue 72 rheumatoid arthritis inflammatory bowel 72 hereditary emphysema 72 vapreotide acetate 72 collagen vascular 72 Phase 2b Clinical Trial 71 neurodegenerative disorder characterized 71 inherited neurodegenerative 71 neuropathic pain spasticity 71 Systemic lupus erythematosus SLE 71 novel orally inhaled 71 alpha1 antitrypsin deficiency 71 personalized cellular immunotherapy 71 including thyroiditis RA 71 arthritis PsA 71 evaluating picoplatin 71 potentially treat nephropathic 71 Lupus Nephritis 71 Demonstrates Positive 71 Files IND 71 Drug Prevents 71 progressive neurodegenerative 71 Novel Oral 71 pharmacogenomic translational research 71 treat chronic sinusitis 71 antiangiogenesis therapies 71 THAT ARE DIFFICULT TO 71 carcinoma mCRC 71 hip osteonecrosis avascular 71 AAG geldanamycin analog 71 investigational oral inhibitor 71 Atypical Hemolytic Uremic Syndrome 71 CIMZIA r certolizumab pegol 71 histologically active 71 Patients Treated With 71 estrogen receptor beta agonist 71 BCG refractory carcinoma 71 ELADUR ™ 71 accumulate preferentially 71 Veronate R 70 swine vesicular 70 targeting Inflammatory Bowel 70 Slow Progression 70 Polyneuropathy 70 PEGylated Fab fragment 70 Initiates Phase II 70 B Anflu R 70 TTR amyloidosis 70 Personalized Immunotherapy 70 nephropathic cystinosis cystinosis 70 metastatic malignant 70 modified glutathione analog 70 Multiple Sclerosis Rheumatoid Arthritis 70 genetic lysosomal storage 70 mediated amyloidosis ATTR hypercholesterolemia 70 Bronchopulmonary Dysplasia 70 indications Dupuytren 70 ALVESCO ® 70 infectious diseases autoimmune diseases 70 IMPDH inhibitor 70 refractory chronic lymphocytic 70 oral dual endothelin 70 M# rationally 70 Ovitrelle R Serostim 70 psoriasis rheumatoid arthritis 70 Prodarsan R 70 Investigational Treatment 70 signal detection CTSD 70 HuCAL PLATINUM ® CysDisplay 70 delivers fluocinolone acetonide FA 70 toenail onychomycosis 70 syndrome overactive bladder 70 Cardium Therapeutics TM 70 Vaccine Shows Promise 70 erythematosus 70 Graft Versus Host 70 deCODE AF TM 70 systemic autoimmune 70 EnteroMedics proprietary neuroblocking technology 70 FDA APPROVES 70 CysDisplay R 70 Physician Insights 70 Refractory Hodgkin Lymphoma 70 Liprotamase 70 ATRA IV 70 targeted radiotherapeutic 70 Slows Progression 70 chronic progressive neurodegenerative 70 hypereosinophilic syndrome 70 include PLX IBD 70 Chronic Sinusitis 70 dasatinib Sprycel ® 70 chronic eosinophilic leukemia 70 Shows Promising 70 FUSILEV enhances 70 diarrhea fatigue asthenia 70 Demonstrates Significant 70 R lenalidomide 70 Combination REOLYSIN R 70 Telik logo TELINTRA 70 lead molecular radiotherapeutic 70 Systemic lupus erythematosus 70 Pharma Merck Serono 70 Improves Outcomes 69 MKC# MT 69 Advanced Melanoma 69 thrombin component 69 rusalatide acetate 69 Mg Usa 69 neuromuscular spasm 69 pan histone deacetylase 69 Transdermal Patch 69 Dementia Related Psychosis 69 Protein Linked 69 JAK2 Inhibitor 69 damage cirrhosis liver 69 treat lupus renal 69 investigational pharmacologically unique 69 Oral Fingolimod 69 PNP inhibitor 69 Drug Shows Promise 69 Adenoviral 69 atypical Hemolytic Uremic Syndrome 69 hypercholesterolemia liver 69 Zemiva TM 69 myelodysplastic myeloproliferative diseases 69 hypertrichosis occurred 69 oral dihydropyrimidine dehydrogenase DPD 69 Soft Tissue Sarcoma 69 milnacipran HCl 69 Effectively Treats 69 systemic lupus erythematosus psoriasis 69 manufactures minimally invasive 69 Symbioscience WISDOM PANEL 69 Drug Candidate 69 severe malignant osteopetrosis 69 INSPIRE Trial Phase III 69 specifically hypoactive sexual 69 acetonide FA 69 Unigene nasal calcitonin 69 albiglutide currently 69 including acne photodamage 69 humans variant Creutzfeldt 69 TNF Blockers 69 Immunotherapeutic 69 vitreoretinal disorders 69 ORLive Presents 69 proprietary radiolabeled monoclonal 69 Virus Linked 69 Successfully Treats 69 Eculizumab 69 cystic fibrosis inflammation autoimmune 69 J Am Acad 69 GVAX ® 69 candidate Zemiva 69 novel VDA molecule 69 6 sulfatase 69 inflammatory demyelinating 69 cystic fibrosis chronic pancreatitis 69 Lower Genital Tract 69 LymphoStat B belimumab 69 rheumatoid arthritis osteoarthritis ankylosing 69 Arrhythmogenic 69 induced mucositis 69 PLX STROKE targeting 69 Pruvel TM 69 DNA methyltransferase inhibitors 69 Phase 2b Trial 69 molecular imaging radiopharmaceutical 69 Mg Uk 69 TRANSDUR ™ 69 plaque buildup restricts 69 BioMarin develops 69 systemic juvenile idiopathic 69 bucindolol hydrochloride 69 METOZOLV ™ ODT metoclopramide 69 Associated Adipose Redistribution 69 dimebon latrepirdine 69 Test Detects 69 Drug Resistant 69 castration resistant hormone refractory 69 Shigatoxin producing E. coli 69 Adjuvant Treatment 69 Submits NDA 69 Clostridium Difficile Associated 69 CDK cyclin dependent 69 DURECT proprietary 69 YOUR LOCAL ANIMAL SHELTER 69 Rare Genetic 69 IMiDs ® 69 Begins Dosing 69 Initiates Dosing 69 Anthrax Toxin 69 dyslipidemia hypertension diabetes 69 pneumocystis pneumonia PCP 69 Hormone Refractory Prostate Cancer 69 Lymphocytic 69 triggers apoptosis programmed 69 metastatic neuroendocrine tumors 69 acute peripheral arterial 68 Initiate Clinical Trial 68 immune idiopathic thrombocytopenic 68 systemic anaplastic large 68 Novel Compound 68 commercializes innovative biopharmaceuticals 68 palonosetron hydrochloride Injection Dacogen 68 Vitrasert ® 68 NEBIDO VANTAS SUPPRELIN LA 68 epilepsy neuropathic pain 68 Granted Orphan Drug 68 Intravenous Human 68 complement inhibitor eculizumab 68 interstitial cystitis IC 68 Vaccine Protects Against 68 Hemorrhagic 68 data management Clintrial 68 ALVESCO R 68 Provectus Pharmaceuticals specializes 68 methylnaltrexone bromide 68 Successfully Treated 68 post herpetic 68 cell carcinoma RCC 68 sickle cell cystic fibrosis 68 receiving chemoradiation therapy 68 erlotinib Tarceva ® 68 J Am Coll 68 oropharyngeal candidiasis OPC 68 By JENNIFER LEARN 68 resistant hormone refractory 68 Bucindolol 68 Nonalcoholic fatty liver 68 Treatment Reduces 68 MANAGEMENT 'S CURRENT BELIEFS 68 Gel repository corticotropin injection 68 See CLINICAL PHARMACOLOGY 68 interferon beta 1a infertility 68 oral prodrug 68 transthyretin TTR 68 Wafer polifeprosan 68 XL# anticancer compounds 68 Kit CD# positive 68 Am J Obstet 68 Commercialize Novel 68 RISKS UNCERTAINTIES AND ASSUMPTIONS 68 Presents Positive 68 Bronchiectasis 68 TELINTRA R 68 recurrent metastatic ovarian cancer 68 CYP#A# isoenzyme 68 Relapsed Refractory 68 Gene Linked 68 PEGylated anti 68 Study Evaluating 68 NicVAX TM 68 Am J Respir 68 colorectal bladder 68 ® bortezomib 68 diabetes sciatica 68 Enlarged Prostate 68 Through Glycoscience R 68 TO TREAT 68 J Antimicrob Chemother 68 doxepin HCl 68 Namenda Memantine HCl 68 Diabetic Macular Edema DME 68 Budesonide foam crofelemer 68 rheumatoid arthritis RA psoriatic 68 Shows Statistically Significant 68 Alzheimer disease cognitive impairment 68 Carcinoid tumors 68 Demonstrates Efficacy 68 Naive Patients 68 involving dopaminergic degeneration 68 Lassa fever Ebola 68 Mylan Receives Approval 68 Philadelphia Chromosome Positive 68 HCl PEPCID ® famotidine 68 autoimmune uveitis 68 inflammatory PDE 68 involuntary dyskinetic movements 68 itraconazole Sporanox 68 syndrome gastroesophageal reflux 68 developing Surfactant Replacement 68 catheter occlusion 68 Factor Receptor 68 Prolongs Survival 68 von Hippel Lindau 68 Aeolus Pharmaceuticals Announces 68 induced macular edema 68 Staphylococcus aureus Immune Globulin 68 coronary stent merged 68 particularly SANCTURA XR 68 REMINDER ORLive Presents 68 R chorionic gonadotropin 68 overactive bladder VANTAS R 68 Prochymal TM 68 bladder ovarian 68 multiple sclerosis psoriasis 68 Luveris R Ovidrel R 68 Fungal Infections 68 MCSP respectively 68 ulcerative colitis Crohn disease 68 Retisert ® 68 Hematology Molecular Pathology 68 include Healive TM 68 MSCRAMM ® 68 Regenerative Cells 68 BUPHENYL ® sodium phenylbutyrate 68 Polymerase Inhibitor 68 Achieves Primary Endpoint 68 either acutely decompensated 68 Vaccine Candidate 68 lexidronam injection 68 ELADUR TM 68 pregnancy bacterial vaginosis 68 Proc Am Soc 68 Peripheral artery 68 aMCI precursor 68 alfimeprase direct 68 Licenses Novel 68 R roscovitine CDK cyclin 68 Severe Sepsis 68 hemophilia von Willebrand 68 Acute Bacterial Skin 68 SPL# Gel vaginal microbicide 68 Endologix Powerlink System 68 Cerebril TM 68 markets COLAZAL 68 MELAS 68 hyperphenylalaninemia HPA due 68 candidates Azedra 68 R MSCRAMM 68 Safinamide 68 bronchospasm dizziness headache 68 Bucindolol Based 68 humanized interleukin 6 68 equine osteoarthritis marketed 68 AFREZZA TM 68 EGFr expressing mCRC 68 metastatic pancreatic 68 Helps Diagnose 68 Demonstrates Sustained 68 Selzentry Celsentri 68 David Rapperport Quest 68 tumor activated prodrug 68 FDA Approves Novel 68 migraines neurorehabilitation 67 Amigal TM 67 autoimmune disorders asthma 67 difficile associated 67 USP Tablets PEPCID 67 Thiarabine 67 Xcytrin R 67 phenylketonuria PKU developed 67 NS5B polymerase 67 Primary Hypercholesterolemia 67 lucinactant 67 identify protein biomarkers 67 Syndrome LEMS 67 Improves Survival 67 allosteric modulator PAM 67 2 methoxyestradiol 67 Leukemias 67 KL4 Surfactant 67 Syncria R 67 DIFICID ™ 67 related CMV Retinitis 67 Zorbtive TM 67 TO AVOID PREGNANCY WHILE 67 PRN FDA Approves 67 Plicera TM 67 endoluminal stent graft 67 SIX RO ROG 67 sunitinib Sutent ® 67 dependent kinase inhibitor 67 Familial Adenomatous Polyposis FAP 67 gastrointestinal mucositis 67 chronically immunosuppressed solid 67 SinuNase TM 67 Parathyroid 67 Presents Preclinical Data 67 occlusion PAO 67 Abstract Accepted 67 Bilive R combined 67 novel proprietary KL4 67 Gene Mutation Linked 67 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 67 hyaluronidase enzyme 67 Study Shows Promise 67 Lymphoid 67 AVI BioPharma Announces 67 Pancreatic insufficiency 67 Schering Plough Remicade 67 NOTE POSIDUR ™ 67 Empatic TM 67 anti botulism antibody 67 peripheral arterial occlusive disease 67 unresectable tumors 67 Chronic Bronchitis 67 highly purified pasteurized 67 orally inhaled migraine 67 approved incretin mimetic 67 Acute Attacks 67 Janus kinase 67 Reports Preclinical Data 67 forodesine purine nucleoside phosphorylase 67 Solazed TM 67 endocrinology gastroenterology 67 Lowers Risk 67 purpura ITP 67 PDE4 modulators 67 Genes Predict 67 Plaque Psoriasis 67 cramping abdominal pain 67 gastrointestinal stromal 67 Inhaled Corticosteroids 67 including eniluracil ADH 67 Central Retinal Vein 67 nanofiltered plasma derived 67 multivessel coronary artery 67 Atopic Dermatitis 67 Hereditary angioedema HAE 67 AN# topical anti 67 infection epistaxis dyspnea exfoliative 67 liver cancers hypercholesterolemia 67 myelofibrosis polycythemia vera 67 RANK Ligand inhibitor 67 pseudomembranous colitis 67 dihydrochloride Tablets 67 Morgellons sufferers describe 67 oral nucleoside analogue 67 hematological cancers notably 67 Phase IIb Trial 67 Vidaza ® 67 factor TNF receptor 67 memantine HCl 67 relapsed leukemia 67 FDA Approves Drug 67 R memantine HCl 67 hypothyroidism hyperglycemia hypotension arrhythmihemorrhagic colitis development 67 Phase 2a Clinical Trial 67 Anti Tumor 67 substantially excreted 67 Zolpimist ™ 67 Progressive Multifocal Leukoencephalopathy 67 inflammation autoimmune diseases 67 novel therapeutic antibodies 67 nilotinib Tasigna ® 67 acid phosphatase PAP 67 virus HCV protease inhibitor 67 transthyretin TTR mediated amyloidosis 67 sapropterin dihydrochloride Phase 67 evaluate ZFP Therapeutic 67 Amvisc Plus TM 67 delivers preprogrammed intermittent 67 product platforms AZX# 67 Myelofibrosis 67 lupus hepatitis C 67 Endocrinol 67 include Phenoptin TM 67 Colaris Colaris AP 67 ODT metoclopramide HCl PEPCID 67 Oral Calcitonin 67 Alfacell proprietary ribonuclease 67 Elestrin ® 67 Solution XOPENEX HFA 67 Onyx Pharmaceuticals Announces 67 RNAi Therapeutic 67 musculoskeletal metabolic 67 #:#-#,# CrossRef Medline [001] 67 ® lenalidomide 67 Frozen Shoulder syndrome Adhesive 67 Vaccine Adjuvant 67 neurotology neuropsychology headaches 67 human IgG1 monoclonal 67 non nucleoside inhibitor 67 Opterone R 67 inflammatory autoimmune diseases 67 THEY SAY THE 67 SCHIZOPHRENIA DISORDERS SUPPORT GROUP 67 polyneuropathy HIV DSP 67 Secondary Hyperparathyroidism 67 Tyrosine Kinase Inhibitor 67 Clin J 67 Endotoxin Activity Assay 67 Preclinical Study 67 PresbyLens ® 67 monoclonal antibody IgG1 Mab 67 aneurysms AAA 67 #-# Full Text 67 Submits Biologics License Application 67 oral Janus kinase 67 targeted anticancer biopharmaceuticals 67 IN PATIENTS WITH 67 neovascular diseases 67 Patients Suffering 67 Causes Symptoms 67 tranquilizers diazepam 67 infection sinusitis 67 Nicotine Vaccine 67 underlying vasculopathy 67 dasatinib Sprycel 67 Orthop Surg 67 clinical trials Archexin 67 Therapies SRT 67 corticotropin injection 67 VEGFR2 inhibitor 67 carcinoids originate 67 Patient Enrollment 67 lupus multiple sclerosis 67 Alseres Cethrin 67 pentadentate logo R 67 reduce serum phosphate 67 oral transdermal 67 topical non steroidal 67 Completes Enrollment 67 Services #:#-#,# Abstract 67 Neovascularization 67 evaluating tivozanib 67 liver cancers TTR 67 novel nucleoside analog 67 include Healive 67 Dosa suffers 67 Receives Approvable Letter 67 hepatitis C lupus 67 FDA Okays 67 CRM# Protein 67 IE INFECTED AND 67 indolent follicular non 67 acquires researches develops 67 developing Bicifadine serotonin 67 predominantly classic subfoveal 67 Am J Clin 67 glaucoma ischemia 67 Streptococcus pneumoniae Haemophilus influenzae 67 Nasdaq AEGR 67 immuno inflammatory diseases 67 Predict Risk 67 idiopathic thrombocytopenic purpura ITP 67 BY STEPHANIE A. WILKEN 67 retinal thrombosis hemorrhages 67 First Patient Treated 67 Receives Orphan Drug 67 common neurovascular complication 67 Proves Effective 67 intravesical infusion therapy 67 Treating Chronic 67 Develop Novel 67 Panzem R 67 Kinase Inhibitor 67 Empatic ™ 67 MTP inhibitor 66 Long acting beta2 66 IMiDs ® compound 66 Phase IIa Clinical Trial 66 MKC# MKC# PP 66 Anthracycline 66 Mouse Models 66 Acute Intermittent Porphyria 66 OMNARIS HFA 66 UCB www.ucb group.com 66 Acute Bacterial Sinusitis ABS 66 Neuroendocrine Tumors 66 Often Misdiagnosed 66 IMiDs R 66 FOLOTYN ® 66 CHEAP ONLINE PHARMACY BEST 66 gemifloxacin mesylate tablets fluoroquinolone 66 Research www. elsevier.com 66 treat male hypogonadism 66 ALN TTR 66 migraine headaches neuropathic pain 66 label Lipofen R 66 Demonstrates Potential 66 Tramiprosate ALZHEMED TM 66 GlycoPEGylated hemostasis compounds 66 based econazole lacquer 66 Gabapentin GR TM 66 treat gastrointestinal disorders 66 cladribine Cladribine Tablets 66 ALN PCS 66 recombinant PSMA vaccine 66 known dihydropyrimidine dehydrogenase 66 sapropterin dihydrochloride Tablets 66 undergoing elective percutaneous 66 Bayer HealthCare Onyx Pharmaceuticals 66 pipeline GlycoPEG GCSF 66 failure thrombosis embolism 66 atopic dermatitis neonatal 66 stiffness stupor disorientation coma 66 gastro intestinal inflammation 66 Occlusive Disease 66 include Alferon N 66 Gets FDA Clearance 66 BY JOHN ECKBERG 66 Histoplasmosis 66 Trial Evaluating 66 Lenocta TM 66 IAP inhibitor 66 Hedgehog Pathway Inhibitor 66 Inhalation Aerosol 66 ALN HPN 66 acute porphyria 66 Morquio 66 attach auristatin 66 Phase IIb Clinical Trial 66 Crit Rev 66 CTAP# 66 PATHFINDER ® TRACER 66 Aflibercept 66 Skin Structure Infections ABSSSI 66 PROSPECTUS PROXY STATEMENT BECAUSE 66 Pegloticase 66 endoscopic autofluorescence imaging 66 Adjuvant Chemotherapy 66 membranous nephritis 66 neovascular wet age 66 Diabetic Foot Ulcer 66 commercialize CorMedix drug 66 Tezampanel 66 periocular infections 66 expanded autologous cellular 66 Friedreich Ataxia FRDA 66 Demonstrate Significant 66 Iluvien ® 66 Alimentary Tract 66 Combivir Kivexa 66 BY JENNIFER BAKER 66 epilepsy neuro oncology 66 Chrysalin r rusalatide acetate 66 candidate deforolimus 66 Therapeutic Efficacy 66 prematurity Stargardt disease 66 LymphoStat B TM 66 mild vasodilator 66 Peginterferon alfa 2b 66 AIDS prophylaxis congestive 66 HAS BEEN PREPARED BY 66 Parkinsonian Syndromes 66 Idiopathic pulmonary fibrosis 66 GI motility disorders 66 follicular Non Hodgkin 66 FOLFOX6 chemotherapy regimen 66 gastrointestinal GI perforation 66 FDA Accepts 66 erosive gastritis 66 selectively inhibit replication 66 CCR9 antagonist 66 Phase 2a Trial 66 P#X# antagonist 66 5 HT4 66 2hours #mins #.#secs M 66 Shows Efficacy 66 delivery polymer matrix 66 Serostim ® 66 autoimmune disorder characterized 66 Sleep Disturbances 66 overactive bladder AA# 66 ADVANCE ILLUMINATE 66 Therapeutic Competitors Companies 66 injectable bulking agent 66 By Neil Osterweil 66 combining voreloxin 66 Cytogen marketed 66 COPEGUS R 66 TNF alpha selectively neutralizing 66 COPEGUS therapy 66 oral beclomethasone dipropionate 66 vinorelbine tartrate 66 GRNOPC1 contains 66 GVT BMF & 66 Eluting Stent 66 FUSILEV ® 66 Initiates Phase III 66 phenylalanine ammonia lyase 66 Announces FDA Clearance 66 Non Alcoholic Fatty 66 R brand levalbuterol 66 Transgenomic Pharmacogenomics Services 66 agonistic human 66 Hormone Receptor Positive 66 Novartis Trileptal 66 MINI Nissan 66 Antitumor Activity 66 Biogen Genentech 66 Cutaneous T 66 Syndax Pharmaceuticals Inc. 66 Stable Coronary Artery 66 Auxilium transmucosal film 66 COPD Chronic Obstructive Pulmonary 66 Pneumocystis pneumonia PCP 66 AND ASSUMPTIONS AND 66 Hepatocellular 66 rheumatoid arthritis systemic lupus 66 autosomal recessive disorder 66 Announce License Agreement 66 neuropathic pain metabolic diseases 66 without uremia 66 R famotidine 66 R BorderGuard 66 Asthma COPD 66 WHO TOOK 66 COVER YOUR BODY 66 Disease Modifying 66 Epidermal Growth Factor Receptor 66 MULLIGAN FAMILY FUN CENTER 66 J Allergy Clin 66 metastatic carcinoid 66 cause mesothelioma asbestosis 66 Warfarin Coumadin 66 Valvular 66 D aspartate NMDA receptor 66 Sciences ABthrax Albuferon 66 hemorrhagic colitis development 66 candidate SMaRT Replacement 66 accessories autologous 66 Includes KCI proprietary 66 tests miRview TM 66 Previously Untreated 66 orally administered inhibitor 66 THE UNDERLYING FUTURE 66 VentiRx Pharmaceuticals 66 commercializing dermatological products 66 induce orthostatic hypotension 66 multiple sclerosis amyotrophic lateral 66 Glucocorticoid 66 myocardial infarction hypersensitivity 66 Alzheimer Disease Parkinson Disease 66 pathophysiological effects 66 R sorafenib tablets 66 Known hypersensitivity 66 Novel Treatments 66 Acute Lung 66 herpetic keratitis 66 CHEAP ONLINE PHARMACY LOW 66 EVENT BRIEFS REFLECTS 66 Marcus Gronholm BP 66 Initiates Clinical 66 5 FU leucovorin 66 Intravitreal 66 Acute Renal Failure 66 TM Aganocide 66 imatinib Gleevec ® 66 tartrate Inhalation Aerosol BROVANA 66 familial amyloidotic polyneuropathy FAP 66 headache abdominal pain 66 NEWLY DIAGNOSED 66 epilepsy Parkinson disease 66 Genotyping Test 66 Bazedoxifene 66 BY RYAN ERNST 66 NYSE PFE Exelon Rivastigmine 66 ABLYNX 66 Uracyst R Test 66 FACTIVE ® 66 Launches Generic Version 66 Nephrol 66 constipation OIC 66 AAT Deficiency 66 ® EBLY ® MASTERFOODS 66 Treatment Resistant 66 Preclinical Data 66 TOWARD THE WEST 66 PET FROM 66 AVAPRO 66 cough nasopharyngeal pain 66 Hsp# Inhibitor 66 Pemphigus Vulgaris 66 RhuDex ™ 66 NASDAQ MSON developer 66 Lupus renal 66 treat benign prostatic 66 psychiatric disorders neurological 66 Chronic Myelogenous Leukemia 66 Neovascular Age Related Macular 66 Int J Radiat Oncol 66 Non Invasive Treatment 66 Nicotine Conjugate Vaccine 66 Celiac sprue 66 Teva Provides Update 66 mGluR2 positive 66 Cancer Incidence Mortality 66 tiapamil 66 cardiovascular restenosis cancer 66 HER2 Positive 66 bone marrow reticulin deposition 66 advanced metastatic renal 66 protein tyrosine phosphatase 1B 66 folate analogue metabolic 66 BY EDWARD CARIFIO 66 Vulvar 66 Respiratory Virus 66 naloxol derivative 66 Antibiotic Resistant 66 Receives CE Marking 66 HCV Hepatitis C 66 delta gamma agonist 66 receiving XGEVA 66 human C1 inhibitor 66 INDUSTRY ASSESSMENTS 66 Epstein Barr Virus EBV 66 allosteric modulator NAM 66 BUT THEIR 66 Aradigm Logo 66 hereditary degenerative 66 HER2 Positive Breast Cancer 66 atypical hemolytic uremic syndrome 66 Postdoctoral Position 66 Reperfusion Injury 66 thetreatment 66 Epratuzumab 66 bone spurs bulging 66 Namenda ® 66 ANCA associated 66 oral proteasome inhibitor 66 Renal Impairment 66 SinuNase ™ 66 next generation URAT1 66 RhuDex R 66 PsA ulcerative colitis 66 intranasal formulation 66 Catheter Associated 66 SANCTURA XR NEBIDO 66 Escherichia coli Klebsiella pneumoniae 66 Bullous 66 By XiaoBing #-#-# 66 bullous 66 hyperplasia BPH 66 deCODE ProstateCancer TM 66 diabetic retinopathy hyphema glaucoma 66 CD# CEA 66 Non Alcoholic Steatohepatitis 66 Injury ALI 66 First Patient Enrolled 66 R Therapy RecoveryRx 66 Peyronie disease Frozen Shoulder 66 metastatic colorectal 66 Metabolic Disorder 66 glaucoma diabetic retinopathy 66 Remission Maintenance 66 Kuvan R 66 PROACT Phase 2 66 sirtuin inhibitor program 65 Amgen Neulasta ® 65 Hemispherx flagship products 65 Clot Busting 65 introduced NEUGENE 65 PRINCE CASPIAN REVIEW 65 NATIONAL ECONOMIC COUNCIL DIRECTOR 65 lintuzumab SGN 65 Reduces Risk 65 Therapy RecoveryRx TM 65 Cell Mol Physiol 65 chorea associated 65 NU# direct 65 alpha folate receptor 65 Bosutinib 65 NS5b 65 By Ed Edelson 65 elderly myelodysplastic syndromes 65 ceroid lipofuscinosis NCL 65 pipeline ImmunoGen collaborators 65 Previously Treated 65 Anti Tumor Activity 65 parathyroid carcinoma 65 prostate secretory 65 Helps Predict 65 Soluble CD# 65 read Palintologist 65 Limb Ischemia 65 developing ostarine selective 65 NEEDS WHICH MAY CAUSE 65 MICRODUR TM 65 Node Positive 65 fibrosis IPF 65 Dose Escalation 65 BSE degenerative nerve 65 sapacitabine CYC# 65 SHORT ON CHEDDAR 65 Renal Cell Carcinoma 65 THE COMPANY 'S STRATEGIES 65 Genes Identified 65 steroid refractory ulcerative 65 selective A2A adenosine receptor 65 diabetes irritable bowel 65 Lupus nephritis 65 TRISCUIT crackers 65 Immunomedics Announces 65 ovarian esophageal 65 lymphoma myeloma 65 Chronic Hepatitis C 65 Prospective Randomized 65 hypervascular tumors 65 Kuvan sapropterin dihydrochloride 65 External Beam 65 TURNING INSIGHTS INTO HOPE 65 II Clinical Trial 65 Myeloma Patients 65 asthma rheumatoid arthritis 65 Oral Solution OSMOPREP 65 commercializing oxidized glutathione 65 opioid induced constipation OIC 65 cromolyn sodium 65 Eur J 65 pediatric endocrinology urology orthopedics 65 Retisert R 65 Numoisyn ® Lozenges 65 Irritable Bowel 65 PF # [002] 65 Vascular Grafts 65 NAVISTAR R 65 Bone Metastases 65 Humanized Anti 65 formerly LymphoStat B 65 metastatic gastric 65 Initiates Clinical Trials 65 SABER ™ 65 MATTERS DISCUSSED IN 65 CytoCore develops cost 65 NSAID associated 65 plus fludarabine 65 chronic rheumatic 65 COLLABORATION WITH 65 bloody diarrhea dehydration 65 gastrointestinal tract diverticulitis gastrointestSteven Fromholz 65 Rheumatoid 65 proprietary HuCNS SC 65 multiple sclerosis inflammatory bowel 65 Biolimus A9 65 Emergent marketed 65 Investigational Oral 65 Refractory Angina 65 products MKC# PP 65 Numoisyn R 65 irinotecan doxorubicin oxaliplatin paclitaxel 65 Systemic Sclerosis 65 soluble tumor necrosis 65 sanofi aventis Bayer Schering 65 Storage Made Simple 65 Telik Announces 65 Oral Suspension USP 65 SILENOR TM doxepin HCl 65 using VIAdel TM 65 By CHRIS GAROFOLO 65 cognitive impairment associated 65 Ischaemic heart 65 Cholesterol Lowering Drug 65 MEK Inhibitor